Short Sellers Lighten Up on Major Biotechs in May
We ran the short selling report that just came out on major NASDAQ biotech stocks to see what the change in short selling was. Interestingly enough, in almost all of the major and large US biotechs...
View ArticleInvitrogen Acquires Applera's Applied Biosystems (IVGN, ABI)
Invitrogen Corp. (NASDAQ: IVGN) has announced a $6.7 Billion cash and stock acquisition for Applera’s Applied Biosystems Group (NYSE: ABI). The breakdown is 45% percent in cash and the 55% in stock....
View ArticleInvestors Overlooking Celera in Applied Bio-Invitrogen Merger? (CRA, ABI,...
There may be a play in this $6.7 Billion merger where Invitrogen Corp. (NASDAQ: IVGN) is acquiring Applera’s Applied Biosystems Group (NYSE: ABI). What is interesting about this Applied Biosystems is...
View ArticleBioHealth & Medical Analyst Calls (AZN, NVS, NVO, CRL, IVGN, APPY, TWTI)
BNP Paribas overseas has lowered ratings of AstraZeneca (NYSE: AZN) to Underperform from Neutral; and raised Novartis (NYSE: NVS) to Neutral from Underperform. Goldman Sachs has raised Novo Nordisk...
View Article
More Pages to Explore .....